Connection

Terry Day to Aged

This is a "connection" page, showing publications Terry Day has written about Aged.
Connection Strength

1.455
  1. Endocrine Mucin-Producing Sweat Gland Carcinoma of the Eyelid With Locoregional Metastasis to the Parotid Gland. Dermatol Surg. 2020 08; 46(8):1116-1118.
    View in: PubMed
    Score: 0.060
  2. Evaluation of a survivorship needs assessment planning tool for head and neck cancer survivor-caregiver dyads. J Cancer Surviv. 2019 02; 13(1):117-129.
    View in: PubMed
    Score: 0.054
  3. Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients. Am J Otolaryngol. 2019 Jan - Feb; 40(1):40-45.
    View in: PubMed
    Score: 0.052
  4. Outcomes and prognostic factors for parotid acinic cell Carcinoma: A National Cancer Database study of 2362 cases. Oral Oncol. 2018 07; 82:53-60.
    View in: PubMed
    Score: 0.051
  5. Preoperative predictors of occult nodal disease in cT1N0 oral cavity squamous cell carcinoma: Review of 2623 cases. Head Neck. 2018 09; 40(9):1967-1976.
    View in: PubMed
    Score: 0.051
  6. Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 04; 158(4):649-659.
    View in: PubMed
    Score: 0.050
  7. Predictors of contralateral-bilateral nodal disease in oropharyngeal cancer: A National Cancer Data Base Study. Head Neck. 2018 02; 40(2):338-348.
    View in: PubMed
    Score: 0.049
  8. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer. Cancer. 2017 Dec 15; 123(24):4841-4850.
    View in: PubMed
    Score: 0.049
  9. Clinical features of ectomesenchymal chondromyxoid tumors: A systematic review of the literature. Oral Oncol. 2017 04; 67:192-197.
    View in: PubMed
    Score: 0.047
  10. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017 Jul 15; 123(14):2651-2660.
    View in: PubMed
    Score: 0.047
  11. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base. Cancer. 2017 Jun 15; 123(12):2248-2257.
    View in: PubMed
    Score: 0.047
  12. Risk Factors Associated With Unplanned Readmission in Patients Undergoing Parotid Cancer Surgery: A Study of the National Cancer Database. JAMA Otolaryngol Head Neck Surg. 2016 06 01; 142(6):544-50.
    View in: PubMed
    Score: 0.045
  13. Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients. Head Neck. 2016 08; 38(8):1208-12.
    View in: PubMed
    Score: 0.045
  14. Prognostic Factors in Myoepithelial Carcinoma of the Major Salivary Glands. Otolaryngol Head Neck Surg. 2016 06; 154(6):1047-53.
    View in: PubMed
    Score: 0.044
  15. Intraoperative goal-directed hemodynamic management in free tissue transfer for head and neck cancer. Head Neck. 2016 04; 38 Suppl 1:E1974-80.
    View in: PubMed
    Score: 0.044
  16. Lymphoepithelial carcinoma of the major salivary glands: Predictors of survival in a non-endemic region. Oral Oncol. 2016 Jan; 52:24-9.
    View in: PubMed
    Score: 0.043
  17. Predictors of Nodal Metastasis in Parotid Malignancies: A National Cancer Data Base Study of 22,653 Patients. Otolaryngol Head Neck Surg. 2016 Jan; 154(1):121-30.
    View in: PubMed
    Score: 0.043
  18. Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 May; 140(5):441-7.
    View in: PubMed
    Score: 0.039
  19. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 Apr; 140(4):331-7.
    View in: PubMed
    Score: 0.039
  20. The association between T-stage and clinical nodal metastasis In HPV-positive oropharyngeal cancer. Am J Otolaryngol. 2014 Jul-Aug; 35(4):463-8.
    View in: PubMed
    Score: 0.038
  21. Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):28-31.
    View in: PubMed
    Score: 0.023
  22. The use of temporal polyethylene implant after temporalis myofascial flap transposition: clinical and radiographic results from its use in 21 patients. J Oral Maxillofac Surg. 2006 Jan; 64(1):12-22.
    View in: PubMed
    Score: 0.022
  23. Systematic review of neuroendocrine carcinomas of the oropharynx. Head Neck. 2022 07; 44(7):1725-1736.
    View in: PubMed
    Score: 0.017
  24. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
    View in: PubMed
    Score: 0.016
  25. Scapular free flap reconstruction of pharyngoesophageal defects. Clin Otolaryngol. 2021 09; 46(5):1110-1113.
    View in: PubMed
    Score: 0.016
  26. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 10; 165(4):536-549.
    View in: PubMed
    Score: 0.016
  27. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119.
    View in: PubMed
    Score: 0.015
  28. Free Flap Inset Techniques in Salvage Laryngopharyngectomy Repair: Impact on Fistula Formation and Function. Laryngoscope. 2021 03; 131(3):E875-E881.
    View in: PubMed
    Score: 0.015
  29. Validation of a Novel, Multidomain Head and Neck Cancer Appearance- and Function-Distress Patient-Reported Outcome Measure. Otolaryngol Head Neck Surg. 2020 11; 163(5):979-985.
    View in: PubMed
    Score: 0.015
  30. Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 05 01; 146(5):455-464.
    View in: PubMed
    Score: 0.015
  31. Temporal Trajectory of Body Image Disturbance in Patients with Surgically Treated Head and Neck Cancer. Otolaryngol Head Neck Surg. 2020 03; 162(3):304-312.
    View in: PubMed
    Score: 0.014
  32. Prognostic factors associated with achieving total oral diet following osteocutaneous microvascular free tissue transfer reconstruction of the oral cavity. Oral Oncol. 2019 11; 98:1-7.
    View in: PubMed
    Score: 0.014
  33. Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Patient-Centered Approach. Otolaryngol Head Neck Surg. 2019 08; 161(2):278-287.
    View in: PubMed
    Score: 0.014
  34. Prognostic factors associated with achieving total oral diet after glossectomy with microvascular free tissue transfer reconstruction. Oral Oncol. 2019 05; 92:59-66.
    View in: PubMed
    Score: 0.014
  35. Factors associated with gastrostomy tube dependence following salvage total laryngectomy with microvascular free tissue transfer. Head Neck. 2019 04; 41(4):865-870.
    View in: PubMed
    Score: 0.013
  36. Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use. Otolaryngol Head Neck Surg. 2019 05; 160(5):855-861.
    View in: PubMed
    Score: 0.013
  37. Causal attributions and their impact on psychosocial functioning in head and neck cancer patient-caregiver dyads: a preliminary, longitudinal study. Qual Life Res. 2019 Apr; 28(4):1105-1109.
    View in: PubMed
    Score: 0.013
  38. Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2018 12 01; 144(12):1105-1114.
    View in: PubMed
    Score: 0.013
  39. Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival. Cancer. 2018 08 01; 124(15):3181-3191.
    View in: PubMed
    Score: 0.013
  40. Swallowing Outcomes in Elderly Patients following Microvascular Reconstruction of the Head and Neck. Otolaryngol Head Neck Surg. 2018 08; 159(2):320-327.
    View in: PubMed
    Score: 0.013
  41. Thirty-day readmission in patients undergoing head and neck microvascular reconstruction. Head Neck. 2018 07; 40(7):1366-1374.
    View in: PubMed
    Score: 0.013
  42. Extracapsular Dissection vs Superficial Parotidectomy of Benign Parotid Lesions: Surgical Outcomes and Cost-effectiveness Analysis. JAMA Otolaryngol Head Neck Surg. 2017 11 01; 143(11):1092-1097.
    View in: PubMed
    Score: 0.012
  43. Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database. Oral Oncol. 2017 09; 72:174-178.
    View in: PubMed
    Score: 0.012
  44. Physical and emotional well-being and support in newly diagnosed head and neck cancer patient-caregiver dyads. J Psychosoc Oncol. 2017 Nov-Dec; 35(6):646-665.
    View in: PubMed
    Score: 0.012
  45. Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1068-74.
    View in: PubMed
    Score: 0.011
  46. Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. 2016 May; 38(5):700-6.
    View in: PubMed
    Score: 0.010
  47. Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma. J Hematol Oncol. 2014 Sep 27; 7:65.
    View in: PubMed
    Score: 0.010
  48. Perioperative survival of elderly head and neck squamous cell carcinoma patients. Laryngoscope. 2014 Oct; 124(10):2281-6.
    View in: PubMed
    Score: 0.010
  49. Thyroid disease and compressive symptoms. Laryngoscope. 2012 Jan; 122(1):13-6.
    View in: PubMed
    Score: 0.008
  50. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
    View in: PubMed
    Score: 0.008
  51. Neural outcomes after plasma knife dissection: a pathologic study and clinical correlation. Head Neck. 2010 Oct; 32(10):1321-7.
    View in: PubMed
    Score: 0.008
  52. Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. Hum Immunol. 2010 Jul; 71(7):659-65.
    View in: PubMed
    Score: 0.007
  53. Respiratory-swallow phase patterns and their relationship to swallowing impairment in patients treated for oropharyngeal cancer. Head Neck. 2010 Apr; 32(4):481-9.
    View in: PubMed
    Score: 0.007
  54. Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope. 2010 Feb; 120(2):236-42.
    View in: PubMed
    Score: 0.007
  55. PET/CT in the assessment of previously treated skull base malignancies. Head Neck. 2010 Jan; 32(1):76-84.
    View in: PubMed
    Score: 0.007
  56. Effectiveness of calcium hydroxylapatite paste in vocal rehabilitation. Ann Otol Rhinol Laryngol. 2009 Aug; 118(8):546-51.
    View in: PubMed
    Score: 0.007
  57. 1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells. Otolaryngol Head Neck Surg. 2009 Feb; 140(2):235-40.
    View in: PubMed
    Score: 0.007
  58. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1313-8.
    View in: PubMed
    Score: 0.007
  59. Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope. 2008 Jul; 118(7):1180-5.
    View in: PubMed
    Score: 0.006
  60. Proximal esophageal stenosis in head and neck cancer patients after total laryngectomy and radiation. ORL J Otorhinolaryngol Relat Spec. 2008; 70(4):229-35.
    View in: PubMed
    Score: 0.006
  61. Radiation dose, driving performance, and cognitive function in patients with head and neck cancer. Radiother Oncol. 2008 May; 87(2):304-7.
    View in: PubMed
    Score: 0.006
  62. Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer. Dermatol Surg. 2008 Apr; 34(4):483-97.
    View in: PubMed
    Score: 0.006
  63. Driving performance in patients with cancer in the head and neck region: a pilot study. Arch Otolaryngol Head Neck Surg. 2007 Sep; 133(9):904-9.
    View in: PubMed
    Score: 0.006
  64. Driving behaviors in patients with head and neck cancer during and after cancer treatment: a preliminary report. Head Neck. 2007 Jul; 29(7):675-81.
    View in: PubMed
    Score: 0.006
  65. Role of mitomycin in upper digestive tract stricture. Head Neck. 2007 Jan; 29(1):12-7.
    View in: PubMed
    Score: 0.006
  66. Muscle-sparing abdominal free flaps in head and neck reconstruction. Head Neck. 2006 Sep; 28(9):802-7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.